Solpadeine soluble tablets

Solpadeine is a widely recognized brand of analgesic medication, famously known for its combination of paracetamol, codeine, and caffeine. The brand was historically developed by SmithKline Beecham, which later became part of GlaxoSmithKline (GSK). In a significant shift in the pharmaceutical market, GSK sold its portfolio of over-the-counter brands, including Solpadeine, to the Belgian-based Omega Pharma in the early 2010s.

Today, Solpadeine is owned by Perrigo Company plc, a leading global provider of over-the-counter consumer goods and self-care products. Perrigo acquired Omega Pharma in 2015, thereby bringing Solpadeine into its extensive portfolio. Manufacturing for Solpadeine occurs across multiple sites depending on the regional market, including facilities in Ireland and other European locations, catering to international distribution networks.